The ICEMVO annual flat fee is charged per market authorization holder to cover, inter alia, the annual costs of the operation and further development of the ICEMVS, costs inherited from the European Medicines Verification Organization and all necessary and legally compulsory activities of the ICEMVO. The level of the annual flat fee contribution is based on actual cost of running the ICEMVO short and long term.
ICEMVO 2022 Annual Fee has been decided by ICEMVO Board of Directors and there will be an overall 10% reduction to the fees from the current year.
ICEMVO 2022 Annual Fee:
- 3,969 € for MAH with IDM 2021 sales turnover above 80,000 €
- 1,215 € for MAH with IDM 2021 sales turnover between 16,000 € to 80,000 €
- 365 € for MAH with IDM 2021 sales below 16,000 €.
For any further information please contact ICEMVO via email email@example.com